Journal Article

Curcumin enhances the anti-obesogenic activity of orlistat through SKN-1/NRF2-dependent regulation of nutrient metabolism in Caenorhabditis elegans

Georgiev, Milen I., Todorova, Monika N., Savova, Martina S., Binev, Biser K., Mihaylova, Liliya V.

2025

Overview

Metabolic dysregulation, a defining feature of obesity, disrupts essential signalling pathways involved in nutrient sensing and mitochondria homeostasis. The nuclear factor erythroid 2-related factor 2 (NRF-2) serves as a pivotal regulator of the cellular stress response, and recent studies have implicated it in the pathogenesis of obesity, diabetes, and metabolic syndrome. Curcumin, a polyphenolic compound derived from turmeric, has been identified as a potent activator of NRF-2. Evidence suggests curcumin impacts obesity and metabolic disorders by modulating gut microbiota composition, increasing energy expenditure, and regulating lipid metabolism. Orlistat, an anti-obesity drug, inhibits fat absorption in the gastrointestinal tract, but its side effects limits its broader use. The present study aims to investigate the potential synergetic effect of a hybrid combination between orlistat and curcumin. Additionally, we provide a detailed understanding of the molecular mechanisms through which this combination mitigates glucose-induced lipid accumulation in Caenorhabditis elegans, with a focus on the role of the skinhead 1 (SKN-1) transcription factor, an orthologue of NRF2. We assessed the lipid accumulation and the changes in skn-1 transcriptional activity in C. elegans using confocal GFP-based detection, alongside mRNA expression analysis of genes from lipid metabolism and oxidative stress response in wild-type, QV225 and LD1 strains. Furthermore, we evaluated locomotion, chemotaxis and mitochondrial dynamics to enhance our understanding of the proposed molecular-based model. Our findings reveal that the orlistat/curcumin combination exerts an anti-obesogenic effect through SKN-1/NRF2-dependent regulation of conserved genes involved in carbohydrate and lipid metabolism in C. elegans. Moreover, the combination stimulates mitochondrial potential, further contributing to the observed synergistic effects. The hybrid combination of orlistat and curcumin demonstrates significant anti-obesity activity by regulating nutrient-sensing pathways through SKN-1/NRF-2 modulation. This approach may allow for the reduction of orlistat dosage, thereby minimizing its adverse effects while maintaining its therapeutic efficacy.

• Publisher: Nature Publishing Group
• Subject: Accumulation / Animals / Anti-Obesity Agents - pharmacology / Caenorhabditis elegans / Caenorhabditis elegans - drug effects / Caenorhabditis elegans - metabolism / Caenorhabditis elegans Proteins - drug effects / Caenorhabditis elegans Proteins - metabolism / Carbohydrate metabolism / Carbohydrates / Cellular stress response / Chemotaxis / Curcumin / Curcumin - pharmacology / Diabetes mellitus / DNA-Binding Proteins - drug effects / DNA-Binding Proteins - metabolism / Drug metabolism / Energy expenditure / GA-binding protein / Gastrointestinal system / Gastrointestinal tract / Gene expression / Gene regulation / Genes / Homeostasis / Intestinal microflora / Lipid metabolism / Lipid Metabolism - drug effects / Lipids / Locomotion / Metabolic disorders / Metabolic syndrome / Metabolism / Mitochondria / Molecular modelling / Nematodes / NF-E2-Related Factor 2 - drug effects / NF-E2-Related Factor 2 - metabolism / Nutrients / Obesity / Obesity - drug therapy / Obesity - metabolism / Orlistat - pharmacology / Oxidative metabolism / Oxidative stress / Pathogenesis / Side effects / Signal transduction / Synergistic effect / Transcription Factors - drug effects / Transcription Factors - metabolism